Cipla Ltd.

Cipla’s subsidiary -- Cipla Health has allotted shares to FIL Capital Investments (Mauritius) II and consequently, the transaction has now been completed. The company’s board at its meeting held on April 12, 2016, has approved for the same.

Cipla has emerged as one of the most respected pharmaceutical names in India as well as across more than 150 countries. Its portfolio includes 1500 plus products across therapeutic categories with one quality standard globally.